Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Donald Bodenner to Thyroid Neoplasms

This is a "connection" page, showing publications Donald Bodenner has written about Thyroid Neoplasms.

 
Connection Strength
  
 
 
1.485
  
  1. Frank RW, Middleton L, Stack BC, Spencer HJ, Riggs AT, Bodenner DL. Conservative management of thyroglobulin-positive, nonlocalizable thyroid carcinoma. Head Neck. 2014 Feb; 36(2):155-7.
    View in: PubMed
    Score: 0.389
  2. Bodenner D, Nalley C, Chien C, Clarke B, Spring PM, Stack BC. Markedly elevated serum calcitonin concentrations associated with initial presentation but not the recurrent presentation of medullary thyroid carcinoma. Thyroid. 2010 Aug; 20(8):927-9.
    View in: PubMed
    Score: 0.320
  3. King DL, Stack BC, Spring PM, Walker R, Bodenner DL. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg. 2007 Sep; 137(3):400-4.
    View in: PubMed
    Score: 0.261
  4. Hinson AM, Massoll NA, Jolly LA, Stack BC, Bodenner DL, Franco AT. Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis. Head Neck. 2017 08; 39(8):1639-1646.
    View in: PubMed
    Score: 0.128
  5. Schlumberger M, Jarzab B, Cabanillas ME, Robinson B, Pacini F, Ball DW, McCaffrey J, Newbold K, Allison R, Martins RG, Licitra LF, Shah MH, Bodenner D, Elisei R, Burmeister L, Funahashi Y, Ren M, O'Brien JP, Sherman SI. A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer. Clin Cancer Res. 2016 Jan 01; 22(1):44-53.
    View in: PubMed
    Score: 0.114
  6. Cabanillas ME, Schlumberger M, Jarzab B, Martins RG, Pacini F, Robinson B, McCaffrey JC, Shah MH, Bodenner DL, Topliss D, Andresen C, O'Brien JP, Ren M, Funahashi Y, Allison R, Elisei R, Newbold K, Licitra LF, Sherman SI, Ball DW. A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment. Cancer. 2015 Aug 15; 121(16):2749-56.
    View in: PubMed
    Score: 0.111
  7. Collins AM, Bodenner D, Chen C, Stone P, Stack BC. Delayed treatment of papillary thyroid carcinoma arising from struma ovarii in a patient with history of bilateral salpingo-oophorectomy: a case report. Endocr Pract. 2012 Jan-Feb; 18(1):e1-4.
    View in: PubMed
    Score: 0.088
  8. Allen SM, Bodenner D, Suen JY, Richter GT. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma. Laryngoscope. 2009 Jul; 119(7):1303-11.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.